TREATMENT OF HEMATOLOGICAL MALIGNANT TUMOR WITH THE HELP OF 2- (4-CHLOROPHENIL) -N - ((2- (2,6-DIOXOPIPERIDIN-3-IL) -1-OXYDISOINDOLIN-5-IL) METHYL -2-2-IL) -1-OXYDISOINDOLIN-5-IL) METILE-2-IL-1-IL) -1-OXYDISOINDOLIN-5-IL) METILE-2-IL-1-IL) -1-OXYDISOINDOLIN-5-IL) METHYL 2-2-IL-1-OXYDISOINDOLIN-5-IL-ILE-2-2-IL-1-OXO-ISOINDOLIN-5-IL-ILE-2-2-IL-1-OXO-ISOINDOLIN-5-IL-ILE-2-2-IL-1-OXY-ISO-DYNDOLIN-5-IL-I-3-OXYDE

摘要

This document presents the treatment, prevention, containment and / or improvement of the condition in leukemia or myelodysplastic syndrome, including the administration of 2- (4-chlorophenyl) -N - ((2- (2,6-dioxopiperidin-3-yl) - 1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide or its stereoisomer or a mixture of its stereoisomers, its isotopolog, pharmaceutically acceptable salt, tautomer, solvate, hydrate, cocrystal, clathrate or polymorph to the patient.